MiR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1

American Journal of Pathology

Volumn 179, Issue 5, 2011, Pages 2580-2588

  Wang, Fenfen ^a   Li, Yang ^a   Zhou, Jiansong ^a   Xu, Junfen ^a   Peng, Chanjuan ^a   Ye, Feng ^a   Shen, Yuanming ^a   Lu, Weiguo ^a   Wan, Xiaoyun ^a   Xie, Xing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 375; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA, NEOPLASM; SP1 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 80054991467     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.07.037     Document Type: Article

References (39)

1. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, P. Perego, G. Favini, L. Ferri, and C. Mangioni Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 1997 535 540
2. P. Biewenga, J. van der Velden, B.W. Mol, L.J. Stalpers, M.S. Schilthuis, J.W. van der Steeg, M.P. Burger, and M.R. Buist Prognostic model for survival in patients with early stage cervical cancer Cancer 117 2011 768 776
3. M.E. Potter, R.D. Alvarez, H.M. Shingleton, S.J. Soong, and K.D. Hatch Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy? Gynecol Oncol 37 1990 78 81
4. H.M. Shingleton, W.B. Jones, A. Russell, A. Fremgen, J.S. Chmiel, K. Ocwieja, D.P. Winchester, and R. Clive Hysterectomy in invasive cervical cancer: a national patterns of care study of the American College of Surgeons J Am Coll Surg 183 1996 393 400
5. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
6. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 2003 787 798
7. Z.S. Wu, Q. Wu, C.Q. Wang, X.N. Wang, J. Huang, J.J. Zhao, S.S. Mao, G.H. Zhang, X.C. Xu, and N. Zhang miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met Cancer 117 2011 2842 2852
8. L.X. Yan, X.F. Huang, Q. Shao, M.Y. Huang, L. Deng, Q.L. Wu, Y.X. Zeng, and J.Y. Shao MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis RNA 14 2008 2348 2360
9. M. Negrini, and G.A. Calin Breast cancer metastasis: a microRNA story Breast Cancer Res 10 2008 203
10. J.W. Lee, C.H. Choi, J.J. Choi, Y.A. Park, S.J. Kim, S.Y. Hwang, W.Y. Kim, T.J. Kim, J.H. Lee, B.G. Kim, and D.S. Bae Altered MicroRNA expression in cervical carcinomas Clin Cancer Res 14 2008 2535 2542
11. Y. Li, F. Wang, J. Xu, F. Ye, Y. Shen, J. Zhou, W. Lu, X. Wan, D. Ma, and X. Xie Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29 J Pathol 224 2011 484 495
12. Y. Shen, Y. Li, F. Ye, F. Wang, W. Lu, and X. Xie Identification of suitable reference genes for measurement of gene expression in human cervical tissues Anal Biochem 405 2010 224 229
13. Z.L. Chen, X.H. Zhao, J.W. Wang, B.Z. Li, Z. Wang, J. Sun, F.W. Tan, D.P. Ding, X.H. Xu, F. Zhou, X.G. Tan, J. Hang, S.S. Shi, X.L. Feng, and J. He microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin J Biol Chem 286 2011 10725 10734
14. B. Li, Y. Hu, F. Ye, Y. Li, W. Lv, and X. Xie Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection Int J Gynecol Cancer 20 2010 597 604
15. D. Hong, W. Lu, F. Ye, Y. Hu, and X. Xie Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells Br J Cancer 101 2009 1798 1804
16. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
17. M.N. Poy, J. Hausser, M. Trajkovski, M. Braun, S. Collins, P. Rorsman, M. Zavolan, and M. Stoffel miR-375 maintains normal pancreatic alpha- and beta-cell mass Proc Natl Acad Sci USA 106 2009 5813 5818
18. W.P. Kloosterman, A.K. Lagendijk, R.F. Ketting, J.D. Moulton, and R.H. Plasterk Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development PLoS Biol 5 2007 e203
19. T. Avnit-Sagi, L. Kantorovich, S. Kredo-Russo, E. Hornstein, and M.D. Walker The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas PLoS One 4 2009 e5033
20. Y. Tsukamoto, C. Nakada, T. Noguchi, M. Tanigawa, L.T. Nguyen, T. Uchida, N. Hijiya, K. Matsuura, T. Fujioka, M. Seto, and M. Moriyama MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta Cancer Res 70 2010 2339 2349
21. A.M. Liu, R.T. Poon, and J.M. Luk MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties Biochem Biophys Res Commun 394 2010 623 627
22. L. Ding, Y. Xu, W. Zhang, Y. Deng, M. Si, Y. Du, H. Yao, X. Liu, Y. Ke, J. Si, and T. Zhou miR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 Cell Res 20 2010 784 793
23. A.B. Hui, M. Lenarduzzi, T. Krushel, L. Waldron, M. Pintilie, W. Shi, B. Perez-Ordonez, I. Jurisica, B. O'Sullivan, J. Waldron, P. Gullane, B. Cummings, and F.F. Liu Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas Clin Cancer Res 16 2010 1129 1139
24. M. Avissar, B.C. Christensen, K.T. Kelsey, and C.J. Marsit MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma Clin Cancer Res 15 2009 2850 2855
25. M. Bloomston, W.L. Frankel, F. Petrocca, S. Volinia, H. Alder, J.P. Hagan, C.G. Liu, D. Bhatt, C. Taccioli, and C.M. Croce MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis JAMA 297 2007 1901 1908
26. P. de Souza Rocha Simonini, A. Breiling, N. Gupta, M. Malekpour, M. Youns, R. Omranipour, F. Malekpour, S. Volinia, C.M. Croce, H. Najmabadi, S. Diederichs, O. Sahin, D. Mayer, F. Lyko, J.D. Hoheisel, and Y. Riazalhosseini Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells Cancer Res 70 2010 9175 9184
27. Y. Li, X. Xu, Y. Liang, S. Liu, H. Xiao, F. Li, H. Cheng, and Z. Fu miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression Int J Clin Exp Pathol 3 2010 254 264
28. S. Lu, and M.C. Archer Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells Int J Cancer 126 2009 416 425
29. J.S. Waby, H. Chirakkal, C. Yu, G.J. Griffiths, R.S. Benson, C.D. Bingle, and B.M. Corfe Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line Mol Cancer 9 2010 275
30. Y. Jiang, L. Wang, W. Gong, D. Wei, X. Le, J. Yao, J. Ajani, J.L. Abbruzzese, S. Huang, and K. Xie A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer Clin Exp Metastasis 21 2004 755 764
31. J.C. Yao, L. Wang, D. Wei, W. Gong, M. Hassan, T.T. Wu, P. Mansfield, J. Ajani, and K. Xie Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer Clin Cancer Res 10 2004 4109 4117
32. P. Yuan, L. Wang, D. Wei, J. Zhang, Z. Jia, Q. Li, X. Le, H. Wang, J. Yao, and K. Xie Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer Cancer 110 2007 2682 2690
33. J. Song, H. Ugai, K. Ogawa, Y. Wang, A. Sarai, Y. Obata, I. Kanazawa, K. Sun, K. Itakura, and K.K. Yokoyama Two consecutive zinc fingers in Sp1 and in MAZ are essential for interactions with cis-elements J Biol Chem 276 2001 30429 30434
34. L. Wang, D. Wei, S. Huang, Z. Peng, X. Le, T.T. Wu, J. Yao, J. Ajani, and K. Xie Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer Clin Cancer Res 9 2003 6371 6380
35. A. Zannetti, S. Del Vecchio, M.V. Carriero, R. Fonti, P. Franco, G. Botti, G. D'Aiuto, M.P. Stoppelli, and M. Salvatore Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma Cancer Res 60 2000 1546 1551
36. I. Martinez, A.S. Gardiner, K.F. Board, F.A. Monzon, R.P. Edwards, and S.A. Khan Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells Oncogene 27 2008 2575 2582
37. X. Wang, H.K. Wang, J.P. McCoy, N.S. Banerjee, J.S. Rader, T.R. Broker, C. Meyers, L.T. Chow, and Z.M. Zheng Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6 RNA 15 2009 637 647
38. C.L. Au Yeung, T.Y. Tsang, P.L. Yau, and T.T. Kwok Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway Oncogene 30 2011 2401 2410
39. G. Narayan, H.A. Pulido, S. Koul, X.Y. Lu, C.P. Harris, Y.A. Yeh, H. Vargas, H. Posso, M.B. Terry, L. Gissmann, A. Schneider, M. Mansukhani, P.H. Rao, and V.V. Murty Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression Oncogene 22 2003 3489 3499